Lygos company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

lygos.com

Founded Year

2011

Stage

Convertible Note | Alive

Total Raised

$202.09M

Last Raised

$160M | 1 mo ago

About Lygos

Lygos creates microbial-based end-to-end manufacturing solutions at the juncture of biology and technology to provide market-changing product opportunities. Lygos' first products -- malonic acid and derivatives -- replace low-quality petrochemical products produced at a high economic and environmental cost in countries without strong environmental protection programs. The company was founded in 2011 and is based in Berkeley, California.

Lygos Headquarter Location

1249 Eighth Street

Berkeley, California, 94710,

United States

510-416-5185

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Lygos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lygos is included in 4 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

305 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

A

Advanced Materials

1,246 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

A

Advanced Manufacturing

55 items

Lygos Patents

Lygos has filed 13 patents.

The 3 most popular patent topics include:

  • Dicarboxylic acids
  • Virus families
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/14/2017

5/10/2022

Dicarboxylic acids, Food additives, Chemical processes, Potassium compounds, Biotechnology

Grant

Application Date

11/14/2017

Grant Date

5/10/2022

Title

Related Topics

Dicarboxylic acids, Food additives, Chemical processes, Potassium compounds, Biotechnology

Status

Grant

Latest Lygos News

SHAREHOLDER ALERT: Weiss Law Reminds FSI, NTUS, ACC, and CMPI Shareholders About Its Ongoing Investigations

Apr 27, 2022

News provided by Share this article If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Flexible Solutions International Inc. (NYSE: FSI ) Weiss Law  is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Flexible Solutions International Inc. (NYSE: FSI ) in connection with the proposed merger of FSI with Lygos, Inc. ("Lygos"). Under the terms of the merger agreement, Lygos issued $160 million worth of convertible notes with a 5.5% fixed annual interest rate and a five-year maturity. The conversion price of the convertible note will be set 12 months to the date of the note, and the pricing terms will be set upon the trading price of the future equity but will be set within a market capitalization range of no less than $250 million or no greater than $350 million. If you own FSI shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/fsi Natus Medical Incorporated (NASDAQ: NTUS ) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated (NASDAQ: NTUS ), in connection with the proposed acquisition of NTUS by an affiliate of ArchiMed. Under the terms of the merger agreement, NTUS shareholders will receive $33.50 in cash for each share of NTUS common stock owned. If you own NTUS shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/ntus American Campus Communities, Inc. (NYSE: ACC ) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of American Campus Communities, Inc. (NYSE: ACC ), in connection with the proposed acquisition of ACC by Blackstone Inc. (NYSE: BX ). Under the terms of the merger agreement, ACC shareholders will receive $65.47 in cash for each share of ACC common stock owned. If you own ACC shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/acc Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI ) Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI ), in connection with the proposed acquisition of CMPI by Regeneron Pharmaceuticals, Inc. via a tender offer. Under the terms of the merger agreement, CMPI shareholders will receive $10.50 in cash for each share of CMPI common stock owned. If you own CMPI shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/cmpi SOURCE Weiss Law

Lygos Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Lygos Rank

  • When was Lygos founded?

    Lygos was founded in 2011.

  • Where is Lygos's headquarters?

    Lygos's headquarters is located at 1249 Eighth Street, Berkeley.

  • What is Lygos's latest funding round?

    Lygos's latest funding round is Convertible Note.

  • How much did Lygos raise?

    Lygos raised a total of $202.09M.

  • Who are the investors of Lygos?

    Investors of Lygos include Paycheck Protection Program, CJ CheilJedang, LG Technology Ventures, Y Combinator, First Round Capital and 10 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.